Guangzhou Improve Med Instrument (300030) - Total Assets

Latest as of September 2025: CN¥1.08 Billion CNY ≈ $158.00 Million USD

Based on the latest financial reports, Guangzhou Improve Med Instrument (300030) holds total assets worth CN¥1.08 Billion CNY (≈ $158.00 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Guangzhou Improve Med Instrument book value and equity for net asset value and shareholders' equity analysis.

Guangzhou Improve Med Instrument - Total Assets Trend (2006–2024)

This chart illustrates how Guangzhou Improve Med Instrument's total assets have evolved over time, based on quarterly financial data.

Guangzhou Improve Med Instrument - Asset Composition Analysis

Current Asset Composition (December 2024)

Guangzhou Improve Med Instrument's total assets of CN¥1.08 Billion consist of 47.4% current assets and 52.7% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	19.9%
Accounts Receivable	CN¥165.41 Million	13.3%
Inventory	CN¥102.88 Million	8.3%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥38.64 Million	3.1%
Goodwill	CN¥7.80 Million	0.6%

Asset Composition Trend (2006–2024)

This chart illustrates how Guangzhou Improve Med Instrument's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Guangzhou Improve Med Instrument.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Guangzhou Improve Med Instrument's current assets represent 47.4% of total assets in 2024, a decrease from 70.3% in 2006.
Cash Position: Cash and equivalents constituted 19.9% of total assets in 2024, up from 9.0% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, unchanged from 3.0% in 2006.
Asset Diversification: The largest asset category is accounts receivable at 13.3% of total assets.

Guangzhou Improve Med Instrument Competitors by Total Assets

Key competitors of Guangzhou Improve Med Instrument based on total assets are shown below.

Company	Country	Total Assets
Gan & Lee Pharmaceuticals Co Ltd SHG:603087	China	CN¥12.14 Billion
Vizionfocus Inc. TW:4771	Taiwan	NT$6.53 Billion
MEDIMI AB AK F:79T	Germany	€1.70 Million
Ansell Ltd AU:ANN	Australia	AU$3.32 Billion
Nanosonics Ltd AU:NAN	Australia	AU$272.48 Million
SDI Ltd AU:SDI	Australia	AU$141.20 Million
Austco Healthcare Ltd AU:AHC	Australia	AU$91.07 Million
Trajan Group Holdings Ltd AU:TRJ	Australia	AU$192.32 Million

Guangzhou Improve Med Instrument - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.26	1.16	1.85
Quick Ratio	0.99	0.91	1.53
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥91.37 Million	CN¥84.39 Million	CN¥395.41 Million

Guangzhou Improve Med Instrument - Advanced Valuation Insights

This section examines the relationship between Guangzhou Improve Med Instrument's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	4.08
Latest Market Cap to Assets Ratio	0.30
Asset Growth Rate (YoY)	-12.7%
Total Assets	CN¥1.24 Billion
Market Capitalization	$376.43 Million USD

Valuation Analysis

Below Book Valuation: The market values Guangzhou Improve Med Instrument's assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Guangzhou Improve Med Instrument's assets decreased by 12.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Guangzhou Improve Med Instrument (2006–2024)

The table below shows the annual total assets of Guangzhou Improve Med Instrument from 2006 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥1.24 Billion ≈ $182.06 Million	-12.75%
2023-12-31	CN¥1.43 Billion ≈ $208.66 Million	-8.49%
2022-12-31	CN¥1.56 Billion ≈ $228.01 Million	-14.62%
2021-12-31	CN¥1.83 Billion ≈ $267.06 Million	+4.60%
2020-12-31	CN¥1.74 Billion ≈ $255.31 Million	+15.79%
2019-12-31	CN¥1.51 Billion ≈ $220.49 Million	-0.29%
2018-12-31	CN¥1.51 Billion ≈ $221.13 Million	-13.44%
2017-12-31	CN¥1.75 Billion ≈ $255.48 Million	+18.78%
2016-12-31	CN¥1.47 Billion ≈ $215.09 Million	+2.12%
2015-12-31	CN¥1.44 Billion ≈ $210.62 Million	+41.20%
2014-12-31	CN¥1.02 Billion ≈ $149.16 Million	+15.43%
2013-12-31	CN¥883.08 Million ≈ $129.22 Million	+15.20%
2012-12-31	CN¥766.53 Million ≈ $112.17 Million	+6.95%
2011-12-31	CN¥716.72 Million ≈ $104.88 Million	+10.05%
2010-12-31	CN¥651.24 Million ≈ $95.30 Million	-1.00%
2009-12-31	CN¥657.84 Million ≈ $96.26 Million	+364.29%
2008-12-31	CN¥141.69 Million ≈ $20.73 Million	+91.78%
2007-12-31	CN¥73.88 Million ≈ $10.81 Million	+84.93%
2006-12-31	CN¥39.95 Million ≈ $5.85 Million	--

About Guangzhou Improve Med Instrument

SHE:300030 China Medical Instruments & Supplies

Market Cap

$376.43 Million

CN¥2.57 Billion CNY

Market Cap Rank

#13956 Global

#4391 in China

Share Price

CN¥8.32

Change (1 day)

+1.84%

52-Week Range

CN¥6.11 - CN¥9.29

All Time High

CN¥22.76